PETALING JAYA: Karex Bhd
anticipates stronger earnings from its synthetic nitrile condom segment beginning from the second quarter of its financial year ending June 30, 2026 (FY26), driven by increased capacity, product innovation, and improving margins, analysts say.
BIMB Research views this as a key catalyst for a medium-term earnings recovery, though it remains cautious about near-term prospects for Karex due to foreign-exchange volatility and rising labour costs.
